TRON gGmbH

TRON, a non-profit research institution based in Mainz, is internationally known for its pioneering work in translational oncology. The institute was founded in 2010 to efficiently translate scientific findings into diagnostic and therapeutic methods.

• Diagnostics and Therapies: TRON develops innovative diagnostics and therapies for diseases such as cancer and others with high medical need. The research focuses on Genomics and Immunology, where novel biomarkers are identified and validated to enable personalized therapies.
• Research Focuses: TRON combines state-of-the-art technologies such as Next-Generation Sequencing, Bioinformatics, Biostatistics, Immunotherapy and Molecular Biology to advance the development of new drugs and medical applications.
• Biomarkers and Immunotherapy: Two central research departments, the Biomarker Development Center (BDC) and the Immunotherapy Development Center (IDC), develop and validate biomarkers as well as immunotherapeutic approaches such as monoclonal antibodies and recombinant vaccines.

TRON's mission is to translate scientific breakthroughs into advances for patients and to bridge the gap between academic basic research and market-oriented pharmaceutical research. Through collaboration with academia and industry, TRON creates new treatment concepts that are quickly transferred into clinical application.

TRON promotes collaboration between science and industry to enable a faster transfer of research results. The new building of the TRON research building in Mainz symbolizes this progress by supporting the education and training of young scientists and Clinician Scientists. However, there is no specific information on explicit sustainability goals of the company in the area of environmental or social responsibility. Nevertheless, TRON contributes to the improvement of public health through its work and strengthens the biotechnology location Mainz.

Recent developments include the planning of a new research building that offers space for excellent research and improves the infrastructure for future advances in cancer and immune research. TRON is thus a central partner in the field of biotechnology and Life Science in Mainz, where it shapes the future of the industry with revolutionary ideas and solutions.

Through its central role in the innovation chain between research and application, TRON will continue to be an important anchor point for biotechnological development in the region.

• 1 - https://www.unimedizin-mainz.de/mct/aktuelles-termine/news/news-detail/article/los-gehts-symbolischer-spatenstich-zum-tron-forschungsneubau.html
• 2 - https://tron-mainz.de/de/datenschutz
• 3 - https://biomindz.com/stories/tron-mainz-science-translation
• 4 - https://tron-mainz.de/de
• 5 - https://www.wissenschaftsallianz-mainz.de/mitglieder/forschungsinstitute/tron